Invivo Therapeutics Holdings Corp.(NASDAQ : NVIV)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||1.29%||89.03||1.0%||$711.02m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.68%||766.39||2.6%||$519.32m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.19%||321.37||1.9%||$493.66m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.47%||105.56||4.2%||$171.26m|
|AXSM||Axsome Therapeutics, Inc.||6.85%||76.90||1.6%||$154.62m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-5.78%||2.12||0.7%||$148.20m|
|MRTX||Mirati Therapeutics, Inc.||5.19%||96.25||1.6%||$147.31m|
|HALO||Halozyme Therapeutics, Inc.||3.55%||59.44||18.4%||$81.17m|
|IMGO||Imago BioSciences, Inc.||0.03%||35.73||0.0%||$57.06m|
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.